April 2017 in “The Journal of urology/The journal of urology” This study found that urologist prescription practices for three common conditions led to nearly $410 million in excess Medicare Part D spending on higher cost and non-generic drugs in 2014.
November 2013 in “Hair transplant forum international” This article discusses the author's experience with prescribing generic finasteride for hair restoration but reports no new clinical findings.
1 citations
,
October 2018 in “Journal of Mind and Medical Sciences” This study found that switching from brand name to generic drugs raises issues like patient and specialist information gaps, lack of collaboration between physicians and pharmacists, ineffective communication, and profit motives.
1 citations
,
January 2013 in “Scholar Commons (University of South Carolina)” This article discusses the regulatory gap in updating labeling responsibilities for generic drugs and argues for the FDA to use negotiated rulemaking to develop more effective drug regulations, but provides no new empirical results.
3 citations
,
January 2018 in “Archives of Disease in Childhood” In this study, researchers at Nottingham Children's Renal Unit found that most pediatric patients switching from Prograf to the generic tacrolimus preparation Adoport maintained stable tacrolimus levels and therapeutic effectiveness, supporting Adoport's use as a cost-saving alternative for the NHS.